Compare Altria Group Inc (MO) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Altria Group Inc vs Stryker Corporation — how do they compare? Altria Group Inc trades at $68.1 (market cap $113.83B), while Stryker Corporation trades at $277.26 (market cap $106.03B). The key difference: Altria Group Inc and Stryker Corporation are close in size by market cap, and Altria Group Inc pays the higher dividend (6.51%). Which is the better fit depends on your goals.
| MO | SYK | |
|---|---|---|
Market Cap | $113.83B | $106.03B |
Sector | Consumer Staples | Technology |
52-Week High | $74.92 | $388.79 |
52-Week Low | $54.72 | $275.39 |
Enterprise Value | $136.04B | $117.50B |
Dividend Yield | 6.51% | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MO trades at $68.18, down 1.02% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed Q2 2026 earnings, beating EPS estimates but missing revenue expectations, and maintains a strong 6.4% dividend yield after its 57th consecutive annual increase. Cash flow from operations remains robust at $9.29 billion for 2025, supporting dividend sustainability despite regulatory headwinds.
Outlook is cautiously optimistic with a consensus price target of $68.50, reflecting Wall Street's buy-heavy ratings. Key risks include ongoing FDA litigation, declining cigarette volumes, and high debt levels. The stock offers income appeal but faces secular challenges in the tobacco industry, requiring careful monitoring of regulatory developments and smoke-free segment growth.
Stryker (SYK) is trading at $276.43, down 8.81% over 24 hours, with a bearish technical signal from moving averages but bullish oscillators. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Strong fundamentals include a net income margin of 14.43% and ROE of 16.51%, though valuation ratios like a P/E of 28.65 are elevated. Recent news includes a securities fraud investigation announcement and the launch of an FDA-cleared surgical app for Apple Vision Pro.
The outlook for SYK is supported by solid profitability and growth initiatives like acquisitions and product launches, but near-term risks include the fraud investigation and competitive pressures. Analyst consensus is strongly bullish with a $376 price target, suggesting significant upside potential if the company navigates current challenges successfully.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
